Home›Stock Screener›Emcure Pharmaceuticals›Quarterly Results

Emcure Pharmaceuticals Quarterly Results

Latest Quarter Net Profit
₹244 Cr
QMar 2026
Quarterly Results

Emcure Pharmaceuticals quarterly results. In Mar 2026, Emcure Pharmaceuticals (EMCURE) reported revenue ₹2,484 Cr and net profit ₹244 Cr — revenue +17.1% YoY. For annual financials, live price and key ratios, visit Emcure Pharmaceuticals share price today.

EMCURE Quarterly Results — Revenue, Profit & EPS Highlights

Emcure Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review EMCURE P/E ratio to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹2,484 Cr in Mar 2026 (-3.8% vs Jun 2026, +17.1% vs Mar 2025)
  • Net Profit of ₹244 Cr in Mar 2026 (-16.7% vs Jun 2026, +23.9% vs Mar 2025)
  • EBITDA of ₹494 Cr in Mar 2026 (-7.7% vs Jun 2026)
  • Operating Margin of 19.0% in Mar 2026 (-2.0pp vs Jun 2026)
  • Earnings Per Share of ₹12.84 in Mar 2026 (-17.2% vs Jun 2026)

Emcure Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EMCURE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 2,484 2,583 2,273 2,121 2,104 -3.8% 17.1%
Net Profit (₹ Cr) 244 293 251 197 215 - -
EBITDA (₹ Cr) 494 535 479 397 417 - -
EPS (₹) 12.84 15.50 12.85 9.97 10.92 - -
Operating Margin (%) 19.0% 21.0% 21.0% 19.0% 20.0% - -

EMCURE Share Price Trend — 1-Year Movement Across Quarterly Results

Emcure Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check EMCURE market value to track the company's total market size over time.

Profitability Ratios

Profit Margin 9.8%
EBITDA Margin 19.9%
Operating Margin 19.0%
ROE (Annual) 19.6%

Balance Sheet Highlights

Total Assets ₹9,613 Cr
Total Equity ₹4,977 Cr
Current Assets ₹5,612 Cr
Current Liabilities ₹724 Cr

Cash Flow Analysis

Operating Cash Flow ₹944 Cr
Investing Cash Flow ₹-1,175 Cr
Financing Cash Flow ₹343 Cr
Net Cash Flow ₹112 Cr

Current Market Data

Current Price ₹1937.10
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 2,121
Sept 2025 2,273
Jun 2026 2,583
Mar 2026 2,484

Net Profit Trend (₹ Cr)

Mar 2025 197
Sept 2025 251
Jun 2026 293
Mar 2026 244

Operating Margin Trend (%)

Mar 2025 19.0%
Sept 2025 21.0%
Jun 2026 21.0%
Mar 2026 19.0%

EMCURE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Emcure Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores